CN Stock MarketDetailed Quotes

002773 Chengdu Kanghong Pharmaceutical Group

Watchlist
  • 17.05
  • -0.19-1.10%
Market Closed Sep 13 15:00 CST
15.68BMarket Cap12.95P/E (TTM)

Chengdu Kanghong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
19.46%2.29B
23.50%1.09B
16.77%3.96B
13.96%3B
8.90%1.92B
-1.16%884.84M
-6.00%3.39B
-7.49%2.63B
-7.18%1.76B
-2.11%895.21M
Operating revenue
19.46%2.29B
23.50%1.09B
16.77%3.96B
13.96%3B
8.90%1.92B
-1.16%884.84M
-6.00%3.39B
-7.49%2.63B
-7.18%1.76B
-2.11%895.21M
Other operating revenue
515.65%797.2K
----
-1.40%626.85K
----
-63.51%129.49K
----
240.28%635.74K
----
546.65%354.86K
----
Total operating cost
13.23%1.51B
16.71%658.81M
13.38%2.81B
12.67%2.07B
12.21%1.34B
-0.18%564.5M
-21.79%2.48B
-18.80%1.83B
-21.35%1.19B
-16.66%565.52M
Operating cost
8.92%234.07M
10.50%114.86M
12.98%438.41M
12.74%326.43M
9.12%214.89M
5.89%103.94M
9.43%388.04M
5.46%289.55M
8.93%196.93M
13.73%98.15M
Operating tax surcharges
8.60%30.93M
37.69%13.2M
15.70%56.08M
12.11%38.17M
9.01%28.48M
-14.68%9.59M
-5.10%48.47M
-8.69%34.05M
-4.31%26.13M
4.37%11.24M
Operating expense
15.70%857.73M
28.76%387.76M
11.41%1.47B
12.12%1.18B
9.25%741.34M
-7.83%301.16M
-5.94%1.32B
-7.23%1.05B
-5.08%678.55M
1.53%326.73M
Administration expense
10.73%228.63M
2.61%95.45M
21.09%472.38M
19.56%306.3M
20.01%206.48M
13.40%93.03M
2.05%390.11M
-0.89%256.19M
7.05%172.06M
17.51%82.04M
Financial expense
-24.55%-32.06M
-37.26%-16.3M
-16.49%-52.35M
-32.20%-39.42M
-65.17%-25.74M
-61.27%-11.87M
-30.92%-44.94M
-19.29%-29.82M
-1.64%-15.58M
2.41%-7.36M
-Interest Income (Financial expense)
-21.84%-31.19M
-30.08%-15.42M
-16.47%-52.5M
-32.96%-40.1M
-62.71%-25.6M
-55.27%-11.85M
-28.33%-45.08M
-21.52%-30.16M
-2.94%-15.73M
4.47%-7.63M
Research and development
13.39%192.87M
-7.02%63.85M
12.75%421.68M
10.08%258.35M
28.69%170.1M
25.46%68.66M
-62.91%374M
-59.67%234.69M
-70.30%132.18M
-72.28%54.73M
Credit Impairment Loss
-49.56%-2.75M
77.61%-356.21K
-687.10%-1.32M
-159.84%-1.04M
-118.49%-1.84M
-153.25%-1.59M
-91.88%224.36K
-186.85%-400.66K
-199.86%-843.05K
-241.30%-628.17K
Asset Impairment Loss
-175.87%-746.32K
----
94.41%-230.53K
113.11%126.53K
201.89%983.62K
----
98.09%-4.13M
-87.66%-965.35K
-87.66%-965.35K
----
Other net revenue
-15.58%38.58M
-19.72%12.57M
8.25%110.68M
-13.04%62.1M
-4.76%45.7M
-29.37%15.65M
220.91%102.24M
-5.14%71.41M
-6.04%47.98M
8.26%22.16M
Fair value change income
---969.6K
--268.8K
---832.8K
---218.4K
----
----
----
----
----
----
Invest income
7.38%19.27M
-103.46%-53.16K
18.31%45.03M
12.56%21.84M
33.30%17.94M
-39.37%1.54M
44.04%38.06M
24.60%19.4M
16.38%13.46M
20,319.20%2.53M
-Including: Investment income associates
52.09%-106.49K
53.56%-53.16K
72.29%-207.24K
40.48%-253.16K
7.74%-222.24K
24.58%-114.47K
-20.69%-747.78K
-8.43%-425.3K
14.07%-240.88K
-1.42%-151.78K
Asset deal income
--13.97K
----
--9.03K
---51.39K
----
----
----
----
----
----
Other revenue
-16.94%23.77M
-19.11%12.71M
-0.09%68.02M
-22.35%41.44M
-21.23%28.62M
-22.45%15.71M
-33.44%68.08M
-10.69%53.37M
-7.26%36.33M
1.22%20.26M
Operating profit
30.13%820.53M
32.90%446.54M
24.20%1.26B
14.45%995.37M
1.52%630.55M
-4.51%335.99M
185.88%1.02B
31.30%869.67M
41.95%621.11M
37.21%351.85M
Add:Non operating Income
-79.36%1.01M
-80.73%249.11K
-94.81%1.37M
-60.55%5.15M
-49.24%4.91M
125.44%1.29M
-53.46%26.45M
-54.85%13.04M
73.18%9.68M
-60.73%573.5K
Less:Non operating expense
-70.50%4.25M
-67.06%805.68K
147.58%28.52M
133.25%18.31M
298.60%14.39M
133.08%2.45M
-38.00%11.52M
-17.10%7.85M
-41.35%3.61M
-72.06%1.05M
Total profit
31.59%817.3M
33.19%445.98M
19.76%1.23B
12.27%982.2M
-0.97%621.08M
-4.71%334.84M
161.88%1.03B
28.33%874.86M
43.52%627.18M
38.26%351.38M
Less:Income tax cost
29.00%130.76M
29.25%74.51M
23.29%202.79M
32.90%165.99M
8.66%101.37M
5.04%57.64M
694.66%164.49M
336.53%124.9M
465.35%93.29M
167.69%54.88M
Net profit
32.10%686.54M
34.01%371.48M
19.09%1.03B
8.83%816.21M
-2.66%519.71M
-6.51%277.2M
105.62%865.81M
14.82%749.96M
26.97%533.9M
26.91%296.5M
Net profit from continuing operation
32.10%686.54M
34.01%371.48M
19.09%1.03B
8.83%816.21M
-2.66%519.71M
-6.51%277.2M
105.62%865.81M
14.82%749.96M
26.97%533.9M
26.91%296.5M
Less:Minority Profit
-0.92%-5.68M
4.17%-2.05M
55.79%-13.64M
-93.18%-9.15M
-76.44%-5.63M
-187.20%-2.14M
-809,682.39%-30.86M
---4.74M
---3.19M
---743.54K
Net profit of parent company owners
31.77%692.22M
33.72%373.52M
16.52%1.04B
9.36%825.36M
-2.19%525.34M
-6.03%279.33M
112.94%896.67M
15.55%754.7M
27.73%537.09M
27.22%297.24M
Earning per share
Basic earning per share
31.58%0.75
36.67%0.41
16.33%1.14
9.76%0.9
-1.72%0.57
-6.25%0.3
113.04%0.98
15.49%0.82
26.09%0.58
28.00%0.32
Diluted earning per share
31.58%0.75
36.67%0.41
16.33%1.14
9.76%0.9
-1.72%0.57
-6.25%0.3
113.04%0.98
15.49%0.82
26.09%0.58
28.00%0.32
Other composite income
-892.21%-470.34K
-90.40%-586.68K
-32.29%-291.3K
-207.67%-205.1K
86.24%-47.4K
-40.49%-308.13K
48.50%-220.2K
146.19%190.5K
-25.98%-344.41K
-1.88%-219.33K
Other composite income of parent company owners
-892.21%-470.34K
-90.40%-586.68K
-32.29%-291.3K
-207.67%-205.1K
86.24%-47.4K
-40.49%-308.13K
48.50%-220.2K
146.19%190.5K
-25.98%-344.41K
-1.88%-219.33K
Total composite income
32.02%686.07M
33.95%370.89M
19.09%1.03B
8.78%816M
-2.60%519.66M
-6.54%276.89M
105.77%865.59M
14.93%750.15M
26.97%533.55M
26.93%296.28M
Total composite income of parent company owners
31.69%691.75M
33.66%372.93M
16.51%1.04B
9.31%825.16M
-2.13%525.29M
-6.06%279.02M
113.11%896.45M
15.65%754.89M
27.73%536.74M
27.25%297.02M
Total composite income of minority owners
-0.92%-5.68M
4.17%-2.05M
55.79%-13.64M
-93.18%-9.15M
-76.44%-5.63M
-187.20%-2.14M
-809,682.39%-30.86M
---4.74M
---3.19M
---743.54K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 19.46%2.29B23.50%1.09B16.77%3.96B13.96%3B8.90%1.92B-1.16%884.84M-6.00%3.39B-7.49%2.63B-7.18%1.76B-2.11%895.21M
Operating revenue 19.46%2.29B23.50%1.09B16.77%3.96B13.96%3B8.90%1.92B-1.16%884.84M-6.00%3.39B-7.49%2.63B-7.18%1.76B-2.11%895.21M
Other operating revenue 515.65%797.2K-----1.40%626.85K-----63.51%129.49K----240.28%635.74K----546.65%354.86K----
Total operating cost 13.23%1.51B16.71%658.81M13.38%2.81B12.67%2.07B12.21%1.34B-0.18%564.5M-21.79%2.48B-18.80%1.83B-21.35%1.19B-16.66%565.52M
Operating cost 8.92%234.07M10.50%114.86M12.98%438.41M12.74%326.43M9.12%214.89M5.89%103.94M9.43%388.04M5.46%289.55M8.93%196.93M13.73%98.15M
Operating tax surcharges 8.60%30.93M37.69%13.2M15.70%56.08M12.11%38.17M9.01%28.48M-14.68%9.59M-5.10%48.47M-8.69%34.05M-4.31%26.13M4.37%11.24M
Operating expense 15.70%857.73M28.76%387.76M11.41%1.47B12.12%1.18B9.25%741.34M-7.83%301.16M-5.94%1.32B-7.23%1.05B-5.08%678.55M1.53%326.73M
Administration expense 10.73%228.63M2.61%95.45M21.09%472.38M19.56%306.3M20.01%206.48M13.40%93.03M2.05%390.11M-0.89%256.19M7.05%172.06M17.51%82.04M
Financial expense -24.55%-32.06M-37.26%-16.3M-16.49%-52.35M-32.20%-39.42M-65.17%-25.74M-61.27%-11.87M-30.92%-44.94M-19.29%-29.82M-1.64%-15.58M2.41%-7.36M
-Interest Income (Financial expense) -21.84%-31.19M-30.08%-15.42M-16.47%-52.5M-32.96%-40.1M-62.71%-25.6M-55.27%-11.85M-28.33%-45.08M-21.52%-30.16M-2.94%-15.73M4.47%-7.63M
Research and development 13.39%192.87M-7.02%63.85M12.75%421.68M10.08%258.35M28.69%170.1M25.46%68.66M-62.91%374M-59.67%234.69M-70.30%132.18M-72.28%54.73M
Credit Impairment Loss -49.56%-2.75M77.61%-356.21K-687.10%-1.32M-159.84%-1.04M-118.49%-1.84M-153.25%-1.59M-91.88%224.36K-186.85%-400.66K-199.86%-843.05K-241.30%-628.17K
Asset Impairment Loss -175.87%-746.32K----94.41%-230.53K113.11%126.53K201.89%983.62K----98.09%-4.13M-87.66%-965.35K-87.66%-965.35K----
Other net revenue -15.58%38.58M-19.72%12.57M8.25%110.68M-13.04%62.1M-4.76%45.7M-29.37%15.65M220.91%102.24M-5.14%71.41M-6.04%47.98M8.26%22.16M
Fair value change income ---969.6K--268.8K---832.8K---218.4K------------------------
Invest income 7.38%19.27M-103.46%-53.16K18.31%45.03M12.56%21.84M33.30%17.94M-39.37%1.54M44.04%38.06M24.60%19.4M16.38%13.46M20,319.20%2.53M
-Including: Investment income associates 52.09%-106.49K53.56%-53.16K72.29%-207.24K40.48%-253.16K7.74%-222.24K24.58%-114.47K-20.69%-747.78K-8.43%-425.3K14.07%-240.88K-1.42%-151.78K
Asset deal income --13.97K------9.03K---51.39K------------------------
Other revenue -16.94%23.77M-19.11%12.71M-0.09%68.02M-22.35%41.44M-21.23%28.62M-22.45%15.71M-33.44%68.08M-10.69%53.37M-7.26%36.33M1.22%20.26M
Operating profit 30.13%820.53M32.90%446.54M24.20%1.26B14.45%995.37M1.52%630.55M-4.51%335.99M185.88%1.02B31.30%869.67M41.95%621.11M37.21%351.85M
Add:Non operating Income -79.36%1.01M-80.73%249.11K-94.81%1.37M-60.55%5.15M-49.24%4.91M125.44%1.29M-53.46%26.45M-54.85%13.04M73.18%9.68M-60.73%573.5K
Less:Non operating expense -70.50%4.25M-67.06%805.68K147.58%28.52M133.25%18.31M298.60%14.39M133.08%2.45M-38.00%11.52M-17.10%7.85M-41.35%3.61M-72.06%1.05M
Total profit 31.59%817.3M33.19%445.98M19.76%1.23B12.27%982.2M-0.97%621.08M-4.71%334.84M161.88%1.03B28.33%874.86M43.52%627.18M38.26%351.38M
Less:Income tax cost 29.00%130.76M29.25%74.51M23.29%202.79M32.90%165.99M8.66%101.37M5.04%57.64M694.66%164.49M336.53%124.9M465.35%93.29M167.69%54.88M
Net profit 32.10%686.54M34.01%371.48M19.09%1.03B8.83%816.21M-2.66%519.71M-6.51%277.2M105.62%865.81M14.82%749.96M26.97%533.9M26.91%296.5M
Net profit from continuing operation 32.10%686.54M34.01%371.48M19.09%1.03B8.83%816.21M-2.66%519.71M-6.51%277.2M105.62%865.81M14.82%749.96M26.97%533.9M26.91%296.5M
Less:Minority Profit -0.92%-5.68M4.17%-2.05M55.79%-13.64M-93.18%-9.15M-76.44%-5.63M-187.20%-2.14M-809,682.39%-30.86M---4.74M---3.19M---743.54K
Net profit of parent company owners 31.77%692.22M33.72%373.52M16.52%1.04B9.36%825.36M-2.19%525.34M-6.03%279.33M112.94%896.67M15.55%754.7M27.73%537.09M27.22%297.24M
Earning per share
Basic earning per share 31.58%0.7536.67%0.4116.33%1.149.76%0.9-1.72%0.57-6.25%0.3113.04%0.9815.49%0.8226.09%0.5828.00%0.32
Diluted earning per share 31.58%0.7536.67%0.4116.33%1.149.76%0.9-1.72%0.57-6.25%0.3113.04%0.9815.49%0.8226.09%0.5828.00%0.32
Other composite income -892.21%-470.34K-90.40%-586.68K-32.29%-291.3K-207.67%-205.1K86.24%-47.4K-40.49%-308.13K48.50%-220.2K146.19%190.5K-25.98%-344.41K-1.88%-219.33K
Other composite income of parent company owners -892.21%-470.34K-90.40%-586.68K-32.29%-291.3K-207.67%-205.1K86.24%-47.4K-40.49%-308.13K48.50%-220.2K146.19%190.5K-25.98%-344.41K-1.88%-219.33K
Total composite income 32.02%686.07M33.95%370.89M19.09%1.03B8.78%816M-2.60%519.66M-6.54%276.89M105.77%865.59M14.93%750.15M26.97%533.55M26.93%296.28M
Total composite income of parent company owners 31.69%691.75M33.66%372.93M16.51%1.04B9.31%825.16M-2.13%525.29M-6.06%279.02M113.11%896.45M15.65%754.89M27.73%536.74M27.25%297.02M
Total composite income of minority owners -0.92%-5.68M4.17%-2.05M55.79%-13.64M-93.18%-9.15M-76.44%-5.63M-187.20%-2.14M-809,682.39%-30.86M---4.74M---3.19M---743.54K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data